STOCK TITAN

RAFINA INNOVATIONS INC - $VICA STOCK NEWS

Welcome to our dedicated page for RAFINA INNOVATIONS news (Ticker: $VICA), a resource for investors and traders seeking the latest updates and insights on RAFINA INNOVATIONS stock.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect RAFINA INNOVATIONS's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of RAFINA INNOVATIONS's position in the market.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.33%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-12.41%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-36.75%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
10.67%
Tags
none
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.61%
Tags
RAFINA INNOVATIONS INC

OTC:VICA

VICA Rankings

VICA Stock Data

12.20k
4.40M
83.45%
Surgical and Medical Instrument Manufacturing
Manufacturing
Link
United States of America
209 Govan Road

About VICA

hci viocare has a dual, complementary business model of 1) creating the first cross-border independent chain of prosthetics & orthotics (p&o) and diabetic foot clinics in emea and 2) developing a portfolio of biomedical technologies to address unmet needs in the diabetic foot, p&o and other health & wellbeing areas, for licensing to established industry participants. the company is listed on the otc markets in the usa, has its executive office in athens, greece and r&d centre in glasgow, uk.